Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients

NCT06079827 is registered in ClinicalTrials.gov with MaxWell Clinic, PLC as lead sponsor.

NCT NCT06079827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06079827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients
Lead sponsor
MaxWell Clinic, PLC
Phase
Observational
Overall status
Unknown status
Start date
March 22, 2022
Completion date
September 1, 2025
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease